Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

Headwinds into opportunity

This article has been updated

Numerous challenges face any emerging company developing a biopharmaceutical. How you anticipate hurdles, plan for contingencies and communicate with stakeholders will play a big part in determining your success.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 22 September 2011

    In the version of this article initially published online, the author wrote, “This suggested a market potential in the billions of dollars…” The sentence should have read, “This suggested a larger market potential…” The error has been corrected for the print, PDF and HTML versions of this article.

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernandes, P. Headwinds into opportunity. Nat Biotechnol 29, 864–866 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing